Leartiker will have new biomedical engineering research laboratories as part of the 2023 Technology Transfer Programme of Bizkaia Provincial Council (BFA), thanks to the grant awarded for the provision of research, testing and experimentation infrastructures.

The addition of a new laboratory for biomedical engineering research will mark a significant leap in the conduct of two of our lines of research: microfluidic technologies and tissue engineering.

As part of the Basque Country's PCTI2030 Personalised Health strategic priority, Leartiker has become firmly established as an expert in the materials and processes involved in rapid diagnosis and regenerative medicine, offering its scientific know-how to both hospitals and businesses in the field of health, and collaborating with them to generate knowledge and new products that will boost the health sector in our region. Additionally, the new facilities for research in the fields of microfluidics and tissue engineering are in line with two of the thematic areas considered priorities by the RIS3 Strategy for the Basque Country: (1) medical devices and technologies; and (2) personalised medicine and advanced therapies.

Covering an area of approximately 60 m², the infrastructure and facilities in question will enable Leartiker to further develop the technology centre's expertise in the field of health. It will also allow it to continue gaining knowledge in technologies used in the design and manufacture of new polymer devices, which will be of great use for individual research projects and for consortiums in different regions, and for transferring this knowledge to industry in the medium to long term.

“Biomedical Engineering Laboratory. Tissue engineering laboratory and organ-on-chip laboratory infrastructure” project, file 6/12/TI/2023/00006, subsidised under the 2023 Technology Transfer programme - Line 2: Grants to set up facilities for research, testing and experimentation.